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1070-129 Elderly Acute Coronary Syndrome Patients Were 
Undertreated With Worse One-Year Outcome: Findings 
From a Contemporary Registry
Raymond T. Yan, Andrew T. Yan, Mary Tan, Chi-Ming Chow, David H. Fitchett, Frank L. 
Ervin, Heather Martin, James Y. Cha, Anatoly Langer, Shaun G. Goodman, Canadian 
Heart Research Centre, Toronto, ON, Canada, University of Toronto, Toronto, ON, 
Canada
Background: Age-related differences in patients with acute coronary syndrome (ACS)
were not well characterized in prior observational studies which often included only cer-
tain age-groups or subjects with myocardial infarction (MI).
Methods: The ACS Registry was a Canadian prospective observational study of 5312
patients with suspected ACS from 51 centres. Baseline demographic data, treatment and
outcome in hospital were recorded on case report forms. One-year outcome was deter-
mined by standardized telephone interview. We examined 4627 patients (87.1%) with
confirmed ACS in three age-groups (in years: <65; 65-74; >75) for differences in clinical
characteristics, treatment and outcome.
Results: Older patients were more often female, with previous angina, MI, or heart fail-
ure. (See Table) 
For trend: *P<0.001; **P=0.039
In multivariable analyses, increasing age was independently associated with reduced uti-
lization of catheterization, PCI and CABG. When further adjusted for treatment differ-
ences, every decade of age increment independently predicted higher risk of death (OR 
[odds ratio] 1.97; P<0.001) and the composite of death and non-fatal MI (OR 1.46; 
P<0.001) at 1-year.
Conclusions: Elderly ACS patients had substantially more complex co-morbidities and 
worse outcome yet they were less likely to be revascularized or receive evidence-based 
therapies. These findings emphasize the ongoing need to evaluate, and to improve 
adherence to, optimal therapeutic regimens for elderly patients. 
1070-130 Sex Difference in Age Dependence of Global and 
Regional Repolarisation Heterogeneity
Peter Smetana, Katerina Hnatkova, Gregory D. Sides, Alexei A. Dmitrienko, Scott A. 
Getzin, Dawn Rebhuhn, Marek Malik, St.George's Hospital Medical School, London, 
United Kingdom, Eli Lilly and Company, Indianapolis, IN
Background: Sex differences of repolarisation heterogeneity (RH) were suggested to
partly explain sex differences in arrhythmic risk. Age related differences in myocardial
structure and function were described repeatedly. However, their influence on RH is still
to be determined. We therefore investigated the influence of age on two ECG-descriptors
of RH. 
Methods: The study used an extensive clinical trial database of 15504 digital 12-lead
resting ECGs obtained in 9351 women and 6153 men of various age groups. From the
median beat of each ECG two descriptors of repolarisation heterogeneity were com-
puted. While a large cosine of the angle between QRS and T vector (TCRT) reflects a
homogeneous global distribution of APDs, high values of the non-dipolar component of
the T wave (TWR) reflect increased local heterogeneities. Individual results were
grouped for women and men. The age relation was analysed in a 10-y window moving in
1-y steps from 20 to 80 ys.
Results: While in men local heterogeneities increased more than in women (men vs
women 20-29yrs: 0.03± 0.04 vs 0.05± 0.06, p<0.005; 70-79yrs: 0.07± 0.05 vs 0.1± 0.1
p=0.227), it was the opposite in global heterogeneity. In men TCRT was only little influ-
enced by age whereas it markedly decreased in women (men vs women 20-29yrs: 0.32±
0.47 vs 0.62± 0.34, p<0.005; 70-79yrs: 0.54± 0.48 vs 0.34± 0.57, p=0.039).
Conclusions: Both global and regional RH is increased at higher age. Therefore age-
related changes of myocardial structure are likely to increase arrhythmic risk.
1070-131 Protective Effect of Diazoxide Is Maintained in Aged 
Heart
Arshad Jahangir, Ekhson Holmuhamedov, Andrew Oberlin, Nadeem Ashfaque, Andre 
Terzic, Mayo Clinic, Rochester, MN
Aging is associated with increased susceptibility of the heart to injury. Diazoxide (D), a
mitochondrial potassium channel opener, have been shown to protect cardiac mitochon-
dria and adult (Ad) heart against ischemia re-oxygenation injury. However the protective
action of diazoxide in aged myocardium, with attenuated ischemic preconditioning, has
not been studied. Mitochondria from senescent hearts (Sn) demonstrated significantly
reduced ability to accumulate and retain extramitochondrial Ca2+, introduced into sus-
pension as a sequential pulses of the known amount of Ca2+ (Figure A). Structural dam-
ages to aged mitochondria induced by Ca2+ overload as evaluated using electron
microscopy images, were significantly attenuated by diazoxide (Figure B). The protective
effect of diazoxide against metabolic stress was also observed in ouabain-stressed aged
cardiomyocytes as diazoxide-mediated suppression of production of free radicals, a criti-
cal mediator of cell injury (Figure C). The rate of production of free radicals in stressed
cardiomyocytes was monitored using confocal microscopy and fluorescent dye, 2,3-
dichlorofluorescein (DCF) diacetate loaded into the cells. Although, diazoxide signifi-
cantly attenuated the ouabain-mediated production of free radicals in adult and aged car-
diomyocytes, the attenuation of radical generation was greater in senescent than adult
cardiomyocytes. Diazoxide also protected the whole aged heart against ischemia and
reperfusion injury. Drop in developed left ventricular pressure following ischemic insult
(C) which was not preserved by endogenous mechanism of ischemic preconditioning
(PC) was significantly improved in the presence of diazoxide. Cardioprotective efficacy of
diazoxide translated also into maintained cellular ATP level. In conclusion, our study
demonstrate that cardioprotective effect of diazoxide could be demonstrated at the level
of isolated mitochondria, single cell and the whole heart, indicating its cardioprotective
potential in aging.
1070-132 Management and Outcome of Elderly Women and Men 
With Acute Coronary Syndromes: A Prospective 
Observational Community-Based Study in 2000 and 
2002
Mady Moriel, Solomon Behar, Dan Tzivoni, Valentina Boyko, Hanoch Hod, Shmuel 
Gottlieb, Neufeld Cardiac Research Institute, Tel HaShomer, Israel
Prior studies have suggested that women (W) with acute myocardial infarction are older,
treated less aggressively and experience worse outcome than men (M).
Purpose: To assess gender differences in treatment and outcome of elderly (age >70y)
patients (pts) with acute coronary syndromes (ACS).
Methods: Elderly ACS pts (511W, 820M) were hospitalized in all 26 CCUs in Israel, dur-
ing 2 prospective 2-months ACS National Surveys conducted in 2000 and 2002.
Results (see Table): After covariate adjustment OR (95% CI) for 7-day mortality, was
higher in W vs M 1.68 (1.08-2.63), but not after 6-months 1.01 (0.73-1.39). The higher
early mortality in W was noted only among ST-elevation (STE) ACS pts: 19.4%W vs
11.5%M; OR 1.96 (1.15-3.37), but not among non-STE ACS pts: 3.9%W vs 3.7%M; OR
0.75 (0.28-1.86).
Conclusion: Elderly W vs M with ACS had similar frequency of STE, complication rates
and received similar medical and revascularization management. The early higher mor-
tality rate in elderly STE-ACS W suggests that an aggressive approach should be
explored in this high risk group.







Thrombolytics/primary PCI (eligible patients)* 72.3 53.4 40.1
Aspirin* 95.3 90.3 88.4
Any Heparin* 93.7 89.9 86.6
Glycoprotein IIb/IIIa inhibitor* 9.2 6.0 3.9
Catheterization* 45.8 40.1 28.5
Percutaneous intervention (PCI)* 20.9 14.1 12.0
Coronary artery bypass graft (CABG)** 4.5 3.9 2.7
Medications Utilization and Outcome at 1-year (%)
Aspirin* 87.6 81.3 75.6
Beta-blockers* 69.1 65.3 60.9
Lipid lowering agents* 75.4 72.3 48.8
Death* 3.2 10.1 20.4
Death/MI* 10.0 16.1 26.5
